IL6 and COVID-19: As an illustration, we showed that total and epicardial adipose tissue, measured using CCTA in combination with blood IL6 levels, are the best predictors of short-term mortality in patients with diabetes and COVID-19, opening an avenue to target patients for preventive corticosteroid therapy that avoids a cytokine storm and subsequent complications [89,90].